Professor Joanna Wardlaw CBE talks about the new SVDs@target programme - Targeting interventions for small vessel disease to prevent stroke and dementia. This programme was funded by a 6 million euro grant from the European Union’s Horizon 2020 programme.
Evaluation of a new test to detect cognitive impairment in patients with small vessel disease stroke
The World Stroke Organization (WHO) reclassify stroke and vascular dementia for the next International Classification of Diseases (ICD).
Following a stroke, many treatments are recommended by health professionals, such as medications to prevent another stroke or physiotherapy to help limb weakness. Stroke survivors often have other chronic illnesses and report finding it difficult to follow treatments recommended by their doctors, nurses and therapists.
An ischaemic stroke happens when a blood clot, or other blockage, cuts off the blood supply to your brain. This is the most common type of stroke.
This fellowship will involve the study of the human eye to find out about the health of the brain’s small blood vessels and nerve connections in people who have recently had a stroke.
Postgraduate fellowship: What is the impact of damaged thinking ability caused by a spontaneous bleed in the brain?
Apathy has a major effect of quality of life for a SVD sufferer; we have shown that for the patient it is more important in determining quality of life than is disability, such as weakness, from the stroke itself.
The Stroke Association's Keynote Lecture is a prestigious event that showcases the latest advancements being made in stroke research.
Find out more about our Keynote Lecture 2016
This guide explains what vascular dementia is, what causes it and what you should do if you are diagnosed with it. It’s aimed at people who have had a stroke or who think they may have vascular dementia.